Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-07

Clinical Trial Update: Antioxidant Carbocysteine Treatment in Obstructive Sleep Apnoea Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluated antioxidant carbocysteine for obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbocisteine (carbocisteine)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Obstructive Sleep Apnoea | NA | Status: COMPLETED